Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00522769 · ClinicalTrials.gov registry record · Phase 1
Cognitive Behavioral Therapy to Treat Bulimia Nervosa in Adolescents
A Phase 1 study, sponsored by Kaiser Permanente.
- Completed
- Registry status
- Phase 1
- Development phase
- 26
- Enrollment target
NCT00522769: Completed Phase 1 study, sponsored by Kaiser Permanente.
NCT00522769 is a Phase 1 study that has completed, run by Kaiser Permanente. The registered enrollment target is 26 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (57% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00522769, a Phase 1 study, has completed, sponsored by Kaiser Permanente.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 26 participants
- Enrollment target
Study Summary
The claire project is a research study testing the use of Cognitive Behavioral Therapy (CBT) to help teenage girls develop healthier eating habits and better ways to manage weight and shape concerns. The study is enrolling girls who are members of the Kaiser Permanente Health plan in the Northwest region. They must be between the ages of 12 and 18 and report binge eating and/or purging (vomiting, laxative or diuretic use) at a research established threshold to be eligible for the study. Girls enrolled in the study will either receive the 6-20 session CBT intervention at the time of enrollment or 6 months after they enroll. Assessments including questions about eating behaviors, mood, and general functioning are given on enrollment in the study, and 3- and 6-months following enrollment (also at 9- and 12-months for those in the delayed treatment condition).
Interventions
- BEHAVIORAL Cognitive Behavioral Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2005-09 |
| Est. Completion | 2009-05 |
| Phase | Phase 1 |
What the finished NCT00522769 record still lists
NCT00522769 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 26 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (57% lower).
The record links to 0 conditions, and to 1 intervention - of which Cognitive Behavioral Therapy is the first listed.
NCT00522769 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00522769 about?
NCT00522769 is a clinical study titled "Cognitive Behavioral Therapy to Treat Bulimia Nervosa in Adolescents". The claire project is a research study testing the use of Cognitive Behavioral Therapy (CBT) to help teenage girls develop healthier eating habits and better ways to manage weight and shape concerns. The study is enrolling girls who are members of the Kaiser Permanente Health plan in the Northwest r...
What is the current status of trial NCT00522769?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 26 participants. The study started on 2005-09. Estimated completion is 2009-05.
What interventions are being tested in trial NCT00522769?
The interventions under investigation include: Cognitive Behavioral Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT00522769?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00522769's enrollment target sits among peer trials
26 1482nd of 2000 higher than 506 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia